StreetInsider.com News Articles

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

Thu, 01 May 2025 08:31:00 -0400

Conference Call and Webcast at 8:30 AM Eastern Time

NEW YORK, May 1, 2025 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it will host a business update conference call and webcast on Thursday, May 15, 2025, at 8:30 AM ET. During the call, Lishan Aklog, M.D., PAVmed's Chairman and Chief Executive Officer, will provide a business

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

Thu, 01 May 2025 08:31:00 -0400

Conference Call and Webcast at 8:30 AM Eastern Time

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

Thu, 01 May 2025 08:31:00 -0400

Conference Call and Webcast at 8:30 AM Eastern Time

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

Thu, 01 May 2025 08:31:00 -0400

Conference Call and Webcast at 8:30 AM Eastern Time

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

Thu, 01 May 2025 08:31:00 -0400

Conference Call and Webcast at 8:30 AM Eastern Time

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

Thu, 01 May 2025 08:31:00 -0400

Conference Call and Webcast at 8:30 AM Eastern Time

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

Thu, 01 May 2025 08:31:00 -0400

Conference Call and Webcast at 8:30 AM Eastern Time

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

Thu, 01 May 2025 08:31:00 -0400

Conference Call and Webcast at 8:30 AM Eastern Time

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

Thu, 01 May 2025 08:31:00 -0400

Conference Call and Webcast at 8:30 AM Eastern Time

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

Thu, 01 May 2025 08:31:00 -0400

Conference Call and Webcast at 8:30 AM Eastern Time

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Tue, 25 Mar 2025 08:01:00 -0400

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies

Veris Health secured financing to resume advancement of implantable physiological monitor through FDA clearance and commercial launch

PAVmed completed debt restructuring and Lucid deconsolidation to regain Nasdaq compliance and strengthen balance sheet

Conference call and webcast to be held today, March 25^th, at 8:30 AM EDT

NEW YORK, March 25, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a